C51.8
BillableMalignant neoplasm of overlapping sites of vulva
Last updated: FY2026 ICD-10-CM (Oct 1, 2025 – Sep 30, 2026) | CMS-HCC V28 (100% phase-in, PY2026)
Is C51.8 an HCC code?
Yes. C51.8 maps to Colorectal, Bladder, and Other Cancers under the CMS-HCC V28 risk adjustment model (and Colorectal, Bladder, and Other Cancers under V24).
HCC Category Mapping
RAF weights shown are the community, non-dual, aged base weights from the CMS risk adjustment model file. Actual per-patient RAF contribution depends on member segment, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains in use during the transition and for historical data.
MEAT Criteria for C51.8
For C51.8 to count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically — it has to be re-documented and supported each calendar year.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed C51.8 during that encounter — not just copy-forwarded from a problem list.
What This Code Means
C51.8 is the ICD-10-CM diagnosis code for malignant neoplasm of overlapping sites of vulva. This code describes cancer that involves multiple overlapping areas of the vulva (the external female genitalia). When a tumor spans across different regions of the vulva without a single clear primary site, this code is used. C51.8 sits in the ICD-10-CM chapter for neoplasms (c00-d49), within the section covering malignant neoplasms of female genital organs (c51-c58).
Under the CMS-HCC V28 risk adjustment model, C51.8 maps to Colorectal, Bladder, and Other Cancers (HCC 22) with a community, non-dual, aged base RAF weight of 0.000. Under the older V24 model, C51.8 mapped to the same category but with a base RAF weight of 0.306 — V28 recalibrated weights across the entire model. V28 is the CMS-HCC risk adjustment model that reached 100% phase-in for payment year 2026, replacing V24 which was used during the PY2024–PY2025 transition.
Use this code only when the malignant tumor involves two or more distinct anatomical sites of the vulva; if a single site is identifiable, use the more specific C51 subcategory instead. Because C51.8 maps to a payment HCC, the provider's documentation must satisfy MEAT criteria (Monitor, Evaluate, Assess, or Treat) for the encounter to count toward the patient's Medicare Advantage risk adjustment score. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.
HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for C51.8 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •Use this code only when the malignant tumor involves two or more distinct anatomical sites of the vulva; if a single site is identifiable, use the more specific C51 subcategory instead
- •Ensure documentation specifies that sites overlap or are multifocal, and verify the histology type is documented separately as it may require an additional code for the morphology
Clinical Significance
Overlapping sites of vulvar cancer indicates malignancy spanning multiple vulvar structures, typically representing more advanced local disease. This code is appropriate when the tumor extends across anatomical boundaries (e.g., labium majus to labium minus, or labium to clitoris) and cannot be classified to a single primary subsite.
Documentation Requirements
- ✓Documentation that tumor involves two or more distinct vulvar subsites
- ✓Identification of specific structures involved (labia majora, labia minora, clitoris)
- ✓Histological type and grade
- ✓TNM staging with depth of invasion
- ✓Lymph node status
- ✓Extent of local invasion documented
- ✓Surgical margins if resection performed